SCHEMBL652524

SCHEMBL652524

CC(C)(C)OC(=O)N1CC[C@H]2CN(c3cccnc3)C[C@H]21

nearest known ligand 0.66

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 7/20 0.66
NR1H2 P55055 1/20 0.51
NR1H3 Q13133 1/20 0.51
CHRNB2 P17787 5/20 0.43
CHRNA4 P43681 5/20 0.43
CHRNA7 P36544 1/20 0.43
CHRNB4 P30926 4/20 0.43
CHRNA3 P32297 4/20 0.43
GRM1 Q13255 2/20 0.43
GRM5 P41594 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL651711 1.00 GPR119 (0.66) GPR119NR1H2NR1H3CHRNB2CHRNA4
SCHEMBL654477 0.94 GPR119 (0.71) GPR119NR1H2NR1H3CHRNB2CHRNA4
SCHEMBL652343 0.94 GPR119 (0.61) GPR119NR1H2NR1H3CHRNB2CHRNA4
SCHEMBL650447 0.94 GPR119 (0.61) GPR119NR1H2NR1H3CHRNB2CHRNA4
SCHEMBL652341 0.94 GPR119 (0.61) GPR119NR1H2NR1H3CHRNB2CHRNA4
SCHEMBL652041 0.90 GPR119 (0.60) GPR119NR1H2NR1H3CHRNB2CHRNA4
SCHEMBL654584 0.83 CHRNB2 (0.47) GPR119NR1H2NR1H3CHRNB2CHRNA4
SCHEMBL650797 0.83 CHRNB2 (0.47) GPR119NR1H2NR1H3CHRNB2CHRNA4
SCHEMBL3579885 0.83 CHRNB2 (0.50) GPR119CHRNB2CHRNA4CHRNA7CHRNB4
SCHEMBL3583096 0.83 CHRNB2 (0.50) GPR119CHRNB2CHRNA4CHRNA7CHRNB4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8119635-B2 Diazabicyclic central nervous system active agents ABBOTT LABORATORIES (US) 2012-02-21 US disclosed
EP-2298775-A1 Diazabicyclic central nervous system active agents Abbott Laboratories (US) 2011-03-23 EP disclosed
EP-2295437-A1 Diazabicyclic central nervous system active agents Abbott Laboratories (US) 2011-03-16 EP disclosed